Several South Korean brokers work at KEB Hana Bank in Seoul, South Korea. . / Kim Hee-chul / Archive

SEOUL, Aug 12 . .- The Seoul Stock Exchange rose on Wednesday for the eighth consecutive day thanks to the expectations of recovery and the Russian announcement about the vaccine against SARS CoV-2, according to local analysts.
The Kospi today gained 13.68 points, 0.57%, to stand at 2,432.35 integers, while the Kosdaq technological index lost 1.7% or 14.63 points, to 845.6 units.
The Kospi started in the red and remained that way for much of a day marked by taking profits after the insistent increases accumulated by the South Korean benchmark.
However, in the last half hour some participants, with retail investors at the forefront, made positive readings about the recovery and the vaccine developed by Russia and thus glimpsed some margin to continue betting on some of the great technological or pharmaceutical values ​​of the Stock Exchange. Seoul
In any case, the main assets of the Kospi reaped mixed closures.
Samsung Electronics, the main value of the South Korean market, finished with an advance of 1.37%, while the world’s second largest microchip manufacturer, SK Hynix, lost 0.37% instead.
Biopharmaceutical company Samsung Biologics gained 4.85%, while Celltrion fell 3.82%.
The main South Korean carmaker, Hyundai Motor, fell 3.91% today and its subsidiary Kia Motors depreciated 4.13%.
By contrast, the POSCO steelmaker was up 0.72% more expensive.
The local currency, the won, gained 0.3 units against the dollar, which at the end of the negotiation was exchanged at 1,185.3 won.